The Myelin-Derived Peptide NSDP1 Suppresses Neuroinflammation and Attenuates Demyelination in Chronic Cuprizone-Fed Mice via Modulation of cGAS–STING Signaling
Neurochemical Research · 2026-06 · 51 (3)
DOI: 10.1007/s11064-026-04802-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 03.06.2026. Verfasst von Junjie Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Demyelinating Diseases, Membrane Proteins, Neuroinflammatory Diseases, Nucleotidyltransferases. Die Arbeit nennt 45 Literaturangaben. Gefördert von: the Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Multiple sclerosis (MS) is characterized by demyelination and neuroinflammation. In a cuprizone (CPZ)-induced demyelination mouse model, proteomic analysis revealed the significant downregulation of a myelin basic protein-derived peptide (sequence: DTGILDSIGRFFS), which we have designated as NSDP1 (nervous system-derived peptide 1). In vitro, NSDP1 suppressed LPS-induced microglial activation in BV2 cells, reducing reactive oxygen species (ROS) production, downregulating pro-inflammatory markers (iNOS, TNF-α, IL-1β), and upregulating the expression of anti-inflammatory marker Arg-1. In vivo, NSDP1 administration via intracerebroventricular injection significantly mitigated CPZ-induced weight loss and demyelination in the corpus callosum. NSDP1 attenuated CPZ-induced demyelination, restoring expression of myelin proteins (MAG, MOG), increasing oligodendrocyte precursor cell (OPC) density, improving myelin sheath ultrastructure, and enhancing axonal myelination efficiency. Furthermore, NSDP1 attenuated CPZ-induced reactive gliosis, reducing both microglial activation and astrocytic reactivity in the corpus callosum. RNA sequencing revealed that NSDP1 modulated myelination-related pathways and correlated with improved locomotor recovery. Mechanistically, NSDP1 exerted its anti-inflammatory effects by inhibiting the cGAS-STING signaling pathway, as shown by reduced cGAS and STING expression in LPS-stimulated BV2 cells. The effects of NSDP1 on ROS and pro-inflammatory cytokine release were reversed by the STING activator DMX and mimicked by the STING inhibitor SN-011. Collectively, these findings identify NSDP1 as a downregulated myelin-derived peptide with potent therapeutic potential, which attenuates demyelination and suppresses neuroinflammation in demyelinating diseases by inhibiting the cGAS-STING pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neurosurgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. njfishxiaohua@163.com.
- Department of Neurosurgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. lxy2186@shtrhospital.com.
Förderung
- the Natural Science Foundation of Shanghai
Zitieren
APA
Yang, J., Chi, Q., Huang, M., Lu, J., Dong, X., & Li, X. (2026). The Myelin-Derived Peptide NSDP1 Suppresses Neuroinflammation and Attenuates Demyelination in Chronic Cuprizone-Fed Mice via Modulation of cGAS–STING Signaling. Neurochemical Research, 51(3). https://doi.org/10.1007/s11064-026-04802-x
Vancouver
Yang J, Chi Q, Huang M, Lu J, Dong X, Li X. The Myelin-Derived Peptide NSDP1 Suppresses Neuroinflammation and Attenuates Demyelination in Chronic Cuprizone-Fed Mice via Modulation of cGAS–STING Signaling. Neurochemical Research. 2026;51(3). doi:10.1007/s11064-026-04802-x
BibTeX
@article{Yang2026,
author = {Yang, Junjie and Chi, Qingze and Huang, Minhao and Lu, Jingcong and Dong, Xiaohua and Li, Xinyuan},
title = {The Myelin-Derived Peptide NSDP1 Suppresses Neuroinflammation and Attenuates Demyelination in Chronic Cuprizone-Fed Mice via Modulation of cGAS–STING Signaling},
journal = {Neurochemical Research},
year = {2026},
volume = {51},
number = {3},
doi = {10.1007/s11064-026-04802-x}
}
EUVIMED